Theophylline improves lipopolysaccharide-induced alveolarization arrest through inflammatory regulation

Molecular Medicine Reports

Volumn 10, Issue 1, 2014, Pages 269-275

  He, Hua ^a   Chen, Fei ^a   Ni, Wensi ^a   Li, Jianhui ^a   Zhang, Yongjun ^a,b  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MOE   (China)

Author keywords

Bronchopulmonary dysplasia; Chorioamnionitis; Cytokine antibody array; Theophylline

Indexed keywords

ANGIOPOIETIN RECEPTOR; BETA CATENIN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR4; CILIARY NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; OREXIN A; OSTEOPONTIN; RESISTIN; THEOPHYLLINE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA; BRONCHODILATING AGENT; CXCL2 CHEMOKINE; CYTOKINE;

ALVEOLARIZATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; INFLAMMATION; LUNG DEVELOPMENT; LUNG STRUCTURE; MORPHOGENESIS; NEWBORN; NONHUMAN; POSTNATAL CARE; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BRONCHOPULMONARY DYSPLASIA; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; LUNG; LUNG ALVEOLUS; METABOLISM; PATHOLOGY; PREGNANCY; TOXICITY;

ANIMALS; ANIMALS, NEWBORN; BRONCHODILATOR AGENTS; BRONCHOPULMONARY DYSPLASIA; CHEMOKINE CCL3; CHEMOKINE CXCL2; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; LUNG; PREGNANCY; PULMONARY ALVEOLI; RATS; THEOPHYLLINE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84901473171     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2188     Document Type: Article

References (31)

1. Choi CW, Kim BI, Hong JS, Kim EK, Kim HS and Choi JH: Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects. Pediatr Res 65: 323-327, 2009.
2. Speer CP: Inflammation and bronchopulmonary dysplasia: A continuing story. Semin Fetal Neonatal Med 11: 354-362, 2006.
3. Jarreau PH, Fayon M, Baud O, Autret-Leca E, Danan M, de Verdelhan A and Castot A: The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations. Arch Pediatr 17: 1480-1487, 2010 (In French).
4. Grier DG and Halliday HL: Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Semin Neonatol 8: 83-91, 2003. (Pubitemid 36356496)
5. To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliott WM, Hogg JC, Adcock IM and Barnes PJ: Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 897-904, 2010.
6. Mascali JJ, Cvietusa P, Negri J and Borish L: Anti-inflammatory effects of theophylline: modulation of cytokine production. Ann Allergy Asthma Immunol 77: 34-38, 1996. (Pubitemid 26264971)
7. Zhu L, Li H, Tang J, Zhu J and Zhang Y: Hyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal rats. Pediatr Pulmonol 47: 264-274, 2012.
8. Coalson JJ: Pathology of bronchopulmonary dysplasia. Semin Perinatol 30: 179-184, 2006.
9. Schreiber T, Niemann C, Schmidt B and Karzai W: A novel model of selective lung ventilation to investigate the long-term effects of ventilation-induced lung injury. Shock 26: 50-54, 2006. (Pubitemid 44297006)
10. Kramer EL, Deutsch GH, Sartor MA, Hardie WD, Ikegami M, Korfhagen TR and Le Cras TD: Perinatal increases in TGF-α disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis. Am J Physiol Lung Cell Mol Physiol 293: L314-L327, 2007. (Pubitemid 47205012)
11. Kim N and Vu TH: Parabronchial smooth muscle cells and alveolar myofibroblasts in lung development. Birth Defects Res C Embryo Today 78: 80-89, 2006. (Pubitemid 43726177)
12. Bland RD: Neonatal chronic lung disease in the post-surfactant era. Biol Neonate 88: 181-191, 2005.
13. Vohr BR, Wright LL, Dusick AM, et al: Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 105: 1216-1226, 2000. (Pubitemid 30346889)
14. Yoon BH, Romero R, Jun JK, et al: Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177: 825-830, 1997. (Pubitemid 27516049)
15. Speer CP, Pabst MJ, Hedegaard HB, Rest RF and Johnston RB Jr: Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G. J Immunol 133: 2151-2156, 1984. (Pubitemid 14035324)
16. Yoon BH, Romero R, Jun JK, et al: Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177: 825-830, 1997. (Pubitemid 27516049)
17. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M and Berry SM: The fetal inflammatory response syndrome. Am J Obstet Gynecol 179: 194-202, 1998. (Pubitemid 28394495)
18. Arnon S, Grigg J and Silverman M: Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment. Arch Dis Child 69: 44-48, 1993. (Pubitemid 23232981)
19. Kotecha S, Chan B, Azam N, Silverman M and Shaw RJ: Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage of premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 72: F90-F96, 1995.
20. Kotecha S, Mildner RJ, Prince LR, et al: The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants Thorax 58: 961-967, 2003. (Pubitemid 37392807)
21. Jones CA, Cayabyab RG, Kwong KY, et al: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 39: 966-975, 1996.
22. Kaneko Y, Takashima K, Suzuki N and Yamana K: Effects of theophylline on chronic inflammatory lung injury induced by LPS exposure in guinea pigs. Allergol Int 56: 445-456, 2007. (Pubitemid 350306398)
23. Ito K, Lim S, Caramori G, et al: A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 99: 8921-8926, 2002. (Pubitemid 34693659)
24. Liang B, Jiang S, Zhang Z, et al: Anti-inflammatory effects of theophylline: modulation of immune functions during murine leukemia virus infection. Immunopharmacol Immunotoxicol 23: 307-319, 2001. (Pubitemid 33031401)
25. Ezeamuzie CI and Shihab PK: Interactions between theophylline and salbutamol on cytokine release in human monocytes. J Pharmacol Exp Ther 334: 302-309, 2010.
26. Marwick JA, Caramori G, Stevenson CS, et al: Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med 179: 542-548, 2009.
27. Bonner JC: The epidermal growth factor receptor at the crossroads of airway remodeling. Am J Physiol Lung Cell Mol Physiol 283: L528-L530, 2002.
28. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE and Daemen MJ: Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22: 975-982, 2002. (Pubitemid 34655226)
29. Shull MM, Ormsby I, Kier AB, et al: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992.
30. Lan HY: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci 7: 1056-1067, 2011.
31. Kitamura H, Cambier S, Somanath S, et al: Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. J Clin Invest 121: 2863-2875, 2011.